TRF2 enriched cytoplasmic chromatin drives cGAS-STAT1-mediated inflammation in senescence.
Key claim: Senescent cells accumulate TRF2-enriched cytoplasmic chromatin fragments that engage cGAS–STAT1 to sustain SASP and reinforce senescence, and metformin or JAK–STAT inhibition can suppress this pathway.
Abstract
Telomere dysfunction, persistent DNA damage, and chronic inflammation are interconnected hallmarks of cellular senescence, but their molecular links remains poorly defined. Here, we find that senescent cells accumulate telomeric protein TRF2-enriched cytoplasmic chromatin fragments (CCFs), which co-localize with γH2AX and H3K27me3 but lack DNA repair proteins, indicating persistent, unrepaired damage. Inflammatory stress, nuclear lamina dysfunction, and progeroid mutations compromise nuclear integrity, promoting nuclear rupture and extrusion of TRF2-bound nuclear DNA fragments into the cytoplasm. TRF2-enriched CCFs engage the cGAS-STAT1 pathway, sustaining SASP production and reinforcing senescence. Pharmacological inhibition of JAK-STAT or metformin treatment suppressed TRF2-enriched CCFs, reduced cGAS-STAT1 activation, DNA damage markers, and SASP. Our study uncovers TRF2-enriched CCFs as a previously unrecognized source of nuclear-derived DNA in senescent cells. We propose that damaged telomeric DNA extruded into the cytoplasm drives chronic immune activation and inflammation, linking nuclear instability to accelerated aging.
Why this matters
Cytosolic DNA sensing has become the dominant mechanistic story for SASP, but the identity of the DNA species has been fuzzy — mitochondrial DNA, micronuclei, retroelements have all been proposed. Identifying TRF2-decorated chromatin fragments as a discrete ligand class ties shelterin/telomere dysfunction directly into the cGAS–STAT1 arm of inflammaging and gives an intersection point where an already-studied drug (metformin) and an approved drug class (JAK inhibitors) plausibly act on the same node, sharpening the biology behind an existing senomorphic pitch.